Tiotropium bromide

por Lipson, David A
Publicado em 2006

The complex relationship between microbial growth rate and yield and its implications for ecosystem processes

por Lipson, David A.
Publicado no Front Microbiol (2015)

Reply to Suissa: Mortality in IMPACT: Confounded by Asthma?

por Lipson, David A., Dransfield, Mark T.
Publicado no Am J Respir Crit Care Med (2020)

Seasonal Changes in an Alpine Soil Bacterial Community in the Colorado Rocky Mountains

por Lipson, David A., Schmidt, Steven K.
Publicado em 2004

Reply to: “Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies” [Letter]

por Barnes, Neil C, Singh, Dave, Lipson, David A
Publicado no Int J Chron Obstruct Pulmon Dis (2021)

Effects of Elevated Atmospheric CO(2) on Soil Microbial Biomass, Activity, and Diversity in a Chaparral Ecosystem

por Lipson, David A., Wilson, Richard F., Oechel, Walter C.
Publicado em 2005

One More Time: The Impact of Inhaled Corticosteroid Withdrawal on IMPACT

por Han, MeiLan K., Lipson, David A., Singh, Dave
Publicado no Am J Respir Crit Care Med (2020)

Reply to Wang and Lai: The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease

por Han, MeiLan K., Lipson, David A., Singh, Dave
Publicado no Am J Respir Crit Care Med (2021)

Reply to López-Campos et al.: Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect

por Lipson, David A., Han, MeiLan K., Wise, Robert
Publicado no Am J Respir Crit Care Med (2021)

Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β(2)-Agonist Therapy: An Integrated Post Hoc Analysis

por Naya, Ian P., Tombs, Lee, Lipson, David A., Compton, Chris
Publicado no Adv Ther (2018)

24-Hour Serial Spirometric Assessment of Once-Daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-Daily Budesonide/Formoterol in Patients with COPD: Analysis of the FULF...

por Lipson, David A., Birk, Ruby, Brealey, Noushin, Zhu, Chang-Qing
Publicado no Adv Ther (2020)

Overview of the Perioperative Management of Lung Volume Reduction Surgery Patients

por Sharafkhaneh, Amir, Falk, Jeremy A., Minai, Omar A., Lipson, David A.
Publicado em 2008

Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis

por Naya, Ian, Tombs, Lee, Lipson, David A., Boucot, Isabelle, Compton, Chris
Publicado no Respir Res (2019)

Organohalide-Respiring Bacteria at the Heart of Anaerobic Metabolism in Arctic Wet Tundra Soils

por Lipson, David A., Raab, Theodore K., Pérez Castro, Sherlynette, Powell, Alexander
Publicado no Appl Environ Microbiol (2021)

Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

por Mehta, Rashmi, Farrell, Colm, Hayes, Siobhán, Birk, Ruby, Okour, Malek, Lipson, David A.
Publicado no Clin Pharmacokinet (2019)

Real-World Treatment Patterns of Multiple-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in UK General Practice

por Sansbury, Leah B, Bains, Chanchal, Lipson, David A, Ismaila, Afisi S, Landis, Sarah H
Publicado no Int J Chron Obstruct Pulmon Dis (2021)

Soil microbial responses to drought and exotic plants shift carbon metabolism

por Pérez Castro, Sherlynette, Cleland, Elsa E., Wagner, Robert, Sawad, Risha Al, Lipson, David A.
Publicado no ISME J (2019)

Efficacy and Safety of Once-Daily Inhaled Umeclidinium in Asian Patients with COPD: Results from a Randomized, Placebo-Controlled Study

por Zhong, Nanshan, Zheng, Jinping, Lee, Sang Haak, Lipson, David A, Du, Xin, Wu, Shunquan
Publicado no Int J Chron Obstruct Pulmon Dis (2020)

Effects of umeclidinium/vilanterol on exercise endurance in COPD: a randomised study

por Riley, John H., Kalberg, Chris J., Donald, Alison, Lipson, David A., Shoaib, Muhammad, Tombs, Lee
Publicado no ERJ Open Res (2018)

Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a r...

por Bremner, Peter R., Birk, Ruby, Brealey, Noushin, Ismaila, Afisi S., Zhu, Chang-Qing, Lipson, David A.
Publicado no Respir Res (2018)